Antioxidation and Tyrosinase Inhibition of Polyphenolic Curcumin Analogs

被引:37
作者
Du, Zhi-Yun [1 ,2 ]
Jiang, Yong-Fu [2 ]
Tang, Zhi-Kai [2 ]
Mo, Rong-Qing [2 ]
Xue, Gui-Hua [2 ]
Lu, Yu-Jing [2 ]
Zheng, Xi [2 ]
Dong, Chang-Zhi [1 ]
Zhang, Kun [2 ]
机构
[1] Univ Paris 07, ITODYS CNRS UMR 7086, F-75205 Paris 13, France
[2] Guandgong Univ Technol, Lab Nat Med & Green Chem, Sch Light Ind & Chem Engn, Guangzhou 510006, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
tyrosinase inhibition; antioxidation; polyphenolic; curcumin analogs; inhibition kinetics; BIOLOGICAL EVALUATION; DERIVATIVES; MECHANISM; SAFETY; COPPER;
D O I
10.1271/bbb.110547
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of polyphenolic curcumin analogs were synthesized and their inhibitory effects on mushroom tyrosinase and the inhibition of 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical formation were evaluated. The results indictated that the analogs possessing m-diphenols and o-diphenols exhibited more potent inhibitory activity on tyrosinase than reference compound rojic acid, and that the analogs with o-diphenols exhibited more potent inhibitory activity of DPPH free-radical formation than reference compound vitamin C. The inhibition kinetics, analyzed by Lineweaver-Burk plots, revealed that compounds B-2 and C-2 bearing o-diphenols were non-competitive inhibitors, while compounds B-11 and C-11 bearing m-diphenols were competitive inhibitors. In particular, representative compounds C-2 and B-11 showed no side effects at a dose of 2,000 mg/kg in a preliminary evaluation of acute toxicity in mice. These results suggest that such polyphenolic curcumin analogs might serve as lead compounds for further design of new potential tyrosinase inhibitors.
引用
收藏
页码:2351 / 2358
页数:8
相关论文
共 38 条
  • [1] Drugs Used to Treat Parkinson's Disease, Present Status and Future Directions
    Abdel-Salam, Omar M. E.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2008, 7 (04) : 321 - 342
  • [2] Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals
    Aggarwal, Bharat B.
    [J]. ANNUAL REVIEW OF NUTRITION, VOL 30, 2010, 30 : 173 - 199
  • [3] Tyrosinase inhibitory effects of 1,3-diphenylpropanes from Broussonetia kazinoki
    Baek, Yoon Su
    Ryu, Young Bae
    Curtis-Long, Marcus J.
    Ha, Tae Joung
    Rengasamy, Rajesh
    Yang, Min Suk
    Park, Ki Hun
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (01) : 35 - 41
  • [4] Design and synthesis of biphenyl derivatives as mushroom tyrosinase inhibitors
    Bao, Kai
    Dai, Yi
    Zhu, Zhi-Bin
    Tu, Feng-Juan
    Zhang, Wei-Ge
    Yao, Xin-Sheng
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (18) : 6708 - 6714
  • [5] Final Report of the Safety Assessment of Kojic Acid as Used in Cosmetics
    Burnett, Christina L.
    Bergfeld, Wilma F.
    Belsito, Donald V.
    Hill, Ronald A.
    Klaassen, Curtis D.
    Liebler, Daniel C.
    Marks, James G., Jr.
    Shank, Ronald C.
    Slaga, Thomas J.
    Snyder, Paul W.
    Andersen, F. Alan
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2010, 29 : 244S - 273S
  • [6] Safety and anti-inflammatory activity of curcumin:: A component of tumeric (Curcuma longa)
    Chainani-Wu, N
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2003, 9 (01) : 161 - 168
  • [7] An Updated Review of Tyrosinase Inhibitors
    Chang, Te-Sheng
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2009, 10 (06): : 2440 - 2475
  • [8] Davis Erica C, 2010, J Clin Aesthet Dermatol, V3, P20
  • [9] Skin lightening preparations and the hydroquinone controversy
    Draelos, Zoe Diana
    [J]. DERMATOLOGIC THERAPY, 2007, 20 (05) : 308 - 313
  • [10] ON THE NATURE AND MODE OF ACTION OF THE COPPERPROTEIN, TYROSINASE .1. EXCHANGE EXPERIMENTS WITH RADIOACTIVE COPPER AND THE RESTING ENZYME
    DRESSLER, H
    DAWSON, CR
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1960, 45 (03) : 508 - 514